QNCX vs VNO · $79.3M cap vs rev $921.3M
Quince Therapeutics, Inc. (QNCX) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
VNO (VNO) common stock.
QNCX does not have a complete income-statement cache yet.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
QNCX currently screens at market cap $79.3M. VNO currently screens at market cap $0.
Not investment advice. Open the QNCX and VNO stock pages for the full models.
Not investment advice.